Promus PREMIER™
Everolimus-Eluting Platinum Chromium Coronary Stent System
Excellent Safety and Performance with Promus PtCr EES1
- Over 10,000 Patients Studied
- Over 3 Million Implanted
The Promus PREMIERTM Stent is the newest member of the PROMUSTM family, featuring the same low dose Everolimus drug and PVDF-HFP polymer combined with the exceptional Platinum Chromium platform. The PLATINUM Clinical Trial Program is the basis for the Promus PREMIER Stent System approval.
![PLATINUM Stent Trial World Map](https://www.bostonscientific.com/en-US/products/stents--coronary/promus-premier-stent-system/clinical-data/_jcr_content/maincontent-par/image_0.img.Premier_DOTTED_WORLDMAP.png)
![PLATINUM Clinical Stent Trials](https://www.bostonscientific.com/en-US/products/stents--coronary/promus-premier-stent-system/clinical-data/_jcr_content/maincontent-par/image.img.premier_Detailedchart_986x1405.png)